95 related articles for article (PubMed ID: 18949544)
1. Cardioprotective and antiarrhythmic effects of resveratrol--a modern perspective on an old treatment: editorial to "resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction" by Chen et al.
Liew R
Cardiovasc Drugs Ther; 2008 Dec; 22(6):427-8. PubMed ID: 18949544
[No Abstract] [Full Text] [Related]
2. Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction.
Chen YR; Yi FF; Li XY; Wang CY; Chen L; Yang XC; Su PX; Cai J
Cardiovasc Drugs Ther; 2008 Dec; 22(6):479-85. PubMed ID: 18853243
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol and derivatives for the treatment of atrial fibrillation.
Baczkó I; Light PE
Ann N Y Acad Sci; 2015 Aug; 1348(1):68-74. PubMed ID: 26205342
[TBL] [Abstract][Full Text] [Related]
4. Favorable effects of resveratrol on sympathetic neural remodeling in rats following myocardial infarction.
Xin P; Pan Y; Zhu W; Huang S; Wei M; Chen C
Eur J Pharmacol; 2010 Dec; 649(1-3):293-300. PubMed ID: 20869962
[TBL] [Abstract][Full Text] [Related]
5. Effects of resveratrol (trans-3,5,4'-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction.
Burstein B; Maguy A; Clément R; Gosselin H; Poulin F; Ethier N; Tardif JC; Hébert TE; Calderone A; Nattel S
J Pharmacol Exp Ther; 2007 Dec; 323(3):916-23. PubMed ID: 17875610
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine.
Das DK; Maulik N
Mol Interv; 2006 Feb; 6(1):36-47. PubMed ID: 16507749
[TBL] [Abstract][Full Text] [Related]
7. Rat Models of Ventricular Fibrillation Following Acute Myocardial Infarction.
Hundahl LA; Tfelt-Hansen J; Jespersen T
J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):514-528. PubMed ID: 28381093
[TBL] [Abstract][Full Text] [Related]
8. [Experimental study of the antiarrhythmic properties of zoniporide].
Spasov AA; Gurova ; Timofeeva AS; Sorokin SM
Eksp Klin Farmakol; 2014; 77(6):13-7. PubMed ID: 25102729
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effect of resveratrol and resveratroloside.
Naumenko SE; Latysheva TV; Gilinsky MA; Rogachev AD; Komarova NI; Salakhutdinov NF; Tolstikov GA
Cardiovasc Hematol Agents Med Chem; 2013 Sep; 11(3):207-10. PubMed ID: 23547903
[TBL] [Abstract][Full Text] [Related]
10. [Role of antiarrhythmics in the post-infarction period].
Dinanian S
Arch Mal Coeur Vaiss; 2000 Apr; 93(3 Spec No):65-9. PubMed ID: 10816803
[TBL] [Abstract][Full Text] [Related]
11. Treatment of ventricular arrhythmias.
Lancet; 1971 Oct; 2(7729):857-8. PubMed ID: 4106879
[No Abstract] [Full Text] [Related]
12. Cardioprotective effect of resveratrol analogue isorhapontigenin versus omega-3 fatty acids in isoproterenol-induced myocardial infarction in rats.
Abbas AM
J Physiol Biochem; 2016 Sep; 72(3):469-84. PubMed ID: 27193109
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide.
Inagaki K; Begley R; Ikeno F; Mochly-Rosen D
Circulation; 2005 Jan; 111(1):44-50. PubMed ID: 15611364
[TBL] [Abstract][Full Text] [Related]
14. Chronic pantoprazole administration and ischemia--reperfusion arrhythmias in vivo in rats--antiarrhythmic or arrhythmogenic?
Abdel-Kawy HS
Cardiovasc Ther; 2015 Apr; 33(2):27-34. PubMed ID: 25677801
[TBL] [Abstract][Full Text] [Related]
15. In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant.
Chen WP; Su MJ; Hung LM
Eur J Pharmacol; 2007 Jan; 554(2-3):196-204. PubMed ID: 17107672
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
Das S; Tosaki A; Bagchi D; Maulik N; Das DK
J Pharmacol Exp Ther; 2006 Jun; 317(3):980-8. PubMed ID: 16525036
[TBL] [Abstract][Full Text] [Related]
17. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
Das B; Sarkar C
Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
[TBL] [Abstract][Full Text] [Related]
18. [Phytoadaptogens-induced phenomenon similar to ischemic preconditioning].
Arbuzov AG; Maslov LN; Burkova VN; Krylatov AV; Konkovskaia IuN; Safronov SM
Ross Fiziol Zh Im I M Sechenova; 2009 Apr; 95(4):398-404. PubMed ID: 19505042
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusion.
Das B; Sarkar C; Shankar PR
Cardiovasc Drugs Ther; 2007 Aug; 21(4):243-51. PubMed ID: 17520332
[TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs.
Lynch JJ; Montgomery DG; Ventura A; Lucchesi BR
J Pharmacol Exp Ther; 1985 Jul; 234(1):72-80. PubMed ID: 3874285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
